Delivery Order SPE2DB22D2206-SPE2DB24FHL08
- Not listed
- This federal contract award, valued at $1,019.75, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VORICONAZOLE 200 MG VIALS, a pharmaceutical product, with a completion date of December 17, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,538,549,458 units of Voriconazole 200mg tablets, which are used to treat fungal infections. The contract has a ceiling value of $77,975.18 and a period of performance through August 2, 2017. It is a Firm Fixed Price Delivery Order contract, with no set-aside...
- This federal contract award is for the delivery of 4,564,730,855 units of VORICONAZOLE 200 MG TABLET 30S to the U.S. government. The award, valued at $1,124.25, was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD) that provides medical supplies and equipment to the military. Amerisourcebergen holds a large...
- The Defense Logistics Agency awarded a delivery order valued at $4,502.43 to AmerisourceBergen Drug Corp for the supply of Voriconazole 40 mg/ml suspension in 75ml quantities. This award, issued on January 9, 2026, with an ultimate completion date of January 12, 2026, represents a firm fixed-price, non-set-aside competitive procurement. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of the pharmaceutical product VYVGART 400 MG/20 ML VIAL 20ML. The contract, valued at $32,414.56, is a firm-fixed price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the U.S. Department of Defense. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, is for the provision of a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract, valued at up to $13,291.92, is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a Delivery Order contract worth $1,009.94 for the supply of medical vials. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a wide range of pharmaceutical products and medical supplies to the U.S. government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract, valued at $1,387.26, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 and...
- This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide a range of prescription medications, over-the-counter drugs, and medical supplies to the U.S. Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract, valued at $2,066.40, is a Delivery Order with a Firm Fixed Price pricing type. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a range of pharmaceutical products and medical supplies to the U.S. government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The award, valued at $2,733.21, is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 and running through...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FHL08Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,730,842 vials of the pharmaceutical drug voriconazole 200 mg. The $2,445.98 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on May 28, 2024, with an ultimate completion date of May 29, 2024. The award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities worldwide, supporting military treatment programs and facilities globally. Additionally, Amerisourcebergen holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 5/28/24 |